Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Schettler

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 22, 2009
A case report of darbepoetin treatment in a patient with sickle cell disease and chronic renal failure undergoing regular hemodialysis procedures that induce a dose-dependent extension of blood transfusion intervalsVolker Schettler, Eberhard Wieland
Atherosclerosis|April 12, 2002
Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresisEberhard Wieland, Volker Schettler, Victor William Armstrong
Atherosclerosis. Supplements|February 5, 2010
The German Lipid Apheresis Registry - remaining to be establishedVolker Schettler, Beate R Jaeger, Reinhard Klingel, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 29, 2011
Impact of lipid apheresis on Egr-1, c-Jun, c-Fos, and Hsp70 gene expression in white blood cellsVolker Schettler, Katrin Völker, Egbert G Schulz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Impact of regular LDL apheresis on the development of restless legs syndromeTobias Tings, Volker Schettler, Monica Canelo, et al.
Clinical Drug Investigation|October 10, 2009
Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre studyEgbert Godehard Schulz, Shadfar Bahri, Volker Schettler, et al.
Atherosclerosis. Supplements|January 30, 2013
Lipoprotein apheresis--more than just cholesterol reduction?Claas L Neumann, Egbert G Schulz, Gerit C Hagenah, et al.
Clinical Research in Cardiology Supplements|April 25, 2012
Current view: indications for extracorporeal lipid apheresis treatmentVolker Schettler, C L Neumann, M Hulpke-Wette, et al.
Atherosclerosis|May 12, 2004
Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up studyAlexander K Scheel, Volker Schettler, Michael Koziolek, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 9, 2015
Long-term effects of 3-month telemetric blood pressure intervention in patients with inadequately treated arterial hypertensionClaas L Neumann, Jan Menne, Volker Schettler, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 22, 2009
A case report of darbepoetin treatment in a patient with sickle cell disease and chronic renal failure undergoing regular hemodialysis procedures that induce a dose-dependent extension of blood transfusion intervalsVolker Schettler, Eberhard Wieland
Atherosclerosis|April 12, 2002
Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresisEberhard Wieland, Volker Schettler, Victor William Armstrong
Atherosclerosis. Supplements|February 5, 2010
The German Lipid Apheresis Registry - remaining to be establishedVolker Schettler, Beate R Jaeger, Reinhard Klingel, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 29, 2011
Impact of lipid apheresis on Egr-1, c-Jun, c-Fos, and Hsp70 gene expression in white blood cellsVolker Schettler, Katrin Völker, Egbert G Schulz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Impact of regular LDL apheresis on the development of restless legs syndromeTobias Tings, Volker Schettler, Monica Canelo, et al.
Clinical Drug Investigation|October 10, 2009
Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre studyEgbert Godehard Schulz, Shadfar Bahri, Volker Schettler, et al.
Atherosclerosis. Supplements|January 30, 2013
Lipoprotein apheresis--more than just cholesterol reduction?Claas L Neumann, Egbert G Schulz, Gerit C Hagenah, et al.
Clinical Research in Cardiology Supplements|April 25, 2012
Current view: indications for extracorporeal lipid apheresis treatmentVolker Schettler, C L Neumann, M Hulpke-Wette, et al.
Atherosclerosis|May 12, 2004
Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up studyAlexander K Scheel, Volker Schettler, Michael Koziolek, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 9, 2015
Long-term effects of 3-month telemetric blood pressure intervention in patients with inadequately treated arterial hypertensionClaas L Neumann, Jan Menne, Volker Schettler, et al.
Pageof 2